Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
The frequency and high mortality of Ebola virus outbreaks highlight the pressing need for diagnostic technologies, especially those that can be used for population surveillance. During public health emergencies, such as those induced by the four outbreaks of Ebola virus in the Democratic Republic of the Congo (DRC) that have occurred in the past 4 years. Antibody serology can also be used to survey a population to provide a more complete estimate of total infections, to begin to understand the immune response of survivors if it is not yet known, and to assess the success of virus containment to guide further control measures. Ebola virus antibodies can be detected by using the Ebola virus envelope glycoprotein ectodomain (GP), which lacks both the transmembrane and the mucin-like domain, as the affinity reagent.